Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю. Урология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа, 2015. 480 с..
Smith C.P. Male chronic pelvic pain: An update. Indian J Urol 2016;32(1):34–9.
Polackwich A.S., Shoskes D.A. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis 2016;19(2):132–8.
Rees J., Abrahams M., Doble A. et al. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int 2015;116(4):509–25.
Grabe M., Bartoletti R., Bjerklund Johansen T.E. et al. Guidelines on urological infections. European Association of Urology, 2015. Pp. 42–46.
Hatzimouratidis K., Eardley I., Giuliano F. et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology, 2015. Pp. 145–60.
Weidner W., Diemer T., Wagenlehner F. Male urogenital infections. Clinical Uro-Andrology. Ed.: V. Mirone. Springer-Verlag Berlin Heidelberg, 2015. Pp. 205–212.
Божедомов В.А., Семенов А.В., Пацановская Г.М. и др. Репродуктивная функция мужчин при хроническом простатите: клинико-анамнестические и микробиологические аспекты. Урология 2015;(1):70–8..
Engeler D., Baranowski A.P., Borovicka J. et al. EAU guidelines on chronic pelvic pain. Guidelines of the European Association of Urology, 2016.
Jungwirth A., Diemer T., Dohle G.R. et al. EAU guidelines on male infertility. European Association of Urology, 2016. P. 6.
Wagenlehner F., vanTill O., Magri V. et al. National Institute of Health Chronic Prostatitis Symptom Index (CPSI) symptom evaluation in patients with chronic prostatitis/chronic pelvic pain syndrome – A multinational study in 1,563 patients. Presented at AUA 2012, abstr #1082.
Anothaisintawee T., Attia J., Nickel J.C. et al. Management of chronic prostatitis/ chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011;305(1):78–86.
Krieger J.N., Lee S.W., Jeon J. et al. Epidemiology of prostatitis. Int J Antimicrob Agents 2008;31(Suppl 1):S85–90.
Nickel J.C. Prostatitis. Can Urol Assoc J 2011;5(5):306–15.
Choi Y.S., Kim K.S., Choi S.W. et al. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate Int 2013;1(3):133–8.
Krieger J.N., Thumbikat P. Bacterial prostatitis: bacterial virulence, clinical outcomes, and new directions. Microbiol Spectr 2016;4(1).
Chen X., Hu C., Peng Y. et al. Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case-control study. Prostate Cancer Prostatic Dis 2016;19(1):92–9.
McNaughton Collins M., Pontari M.A., O’Leary M.P. et al. Quality of life is impaired in men with chronic prostatitis: the chronic prostatitis collaborative research network. J Gen Intern Med 2001;16(10):656–62.
Magri V., Marras E., Restelli A. et al. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med 2015;9(3):658–66.
Shoskes D.A., Nickel J.C., Kattan M.W. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 2010;75(6):1249–53.
Стандарт первичной медико-санитарной помощи при хроническом простатите (Приложение к приказу Министерства здравоохранения РФ от 09.11.2012 № 775н)..
Lotti F., Corona G., Mondaini N. et al. Seminal, clinical and colour-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples. Andrology 2014;2(1):30–41.
Коган М.И., Белоусов И.И., Болоцков А.С. Артериальный кровоток в простате при синдроме хронической тазовой боли/хроническом простатите. Урология 2011;(3):22–8..
FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. May 12, 2016. Available at:http://www.fda.gov/Drugs/DrugSafety/ucm500143. htm(дата обращения 27.05.2016).
Kelley K.J. FDA calls for more restriction on fluoroquinolone use. Medical news. Physicians first watch. Eds. by: S. Sadoughi, A. Sofair. May 16, 2016.
Винаров А.З., Стойлов С.В., Козырев С.В. и др. Лечение больных простатитом доксициклином (Юнидокс Солютаб®) и/или джозамицином (Вильпрафен®) в реальной клинической практике. Результаты наблюдательной программы TAURUS. Урология 2015;(3):75–8, 80–3..
Mishra V.C., Browne J., Emberton M. Role of repeated prostatic massage in chronic prostatitis: a systematic review of the literature. Urology 2008;72(4):731–5.
ThakkinstianA., Attia J., AnothaisintaweeT., Nickel J.C. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/ chronic pelvic pain syndrome. BJU Int 2012;110(7):1014–22.
Cohen J.M., Fagin A.P., Hariton E. et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and metaanalysis. PLoS One 2012;7(8):e41941.
Chiang P.H., Chiang C.P. Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa. Int J Urol 2004;11(2):97–102.
Kastner C., Hochreiter W., Huidobro C. et al. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis – results of a pilot study after 1 year. Urology 2004;64(6):1149–54.
Гаджиева З.К., Казилов Ю.Б. Обоснование комбинированной медикаментозной терапии симптомов нижних мочевыводящих путей с использованием α1-адреноблокатора и М-холиноблокатора. Урология 2016;(1):91–8..
Nickel J.C., Roehrborn C., Montorsi F. et al. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. J Urol 2011;186(4):1313–8.
Clemens J.Q., Nadler R.B., Schaeffer A.J. et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000;56(6):951–5.
Cornel E.B., van Haarst E.P., Schaarsberg R.W., Geels J. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005;47(5):607–11.
He W., Chen M., Zu X. et al. Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment. BJU Int 2010;105(7):975–7.
Ginting J.V., Tripp D.A., Nickel J.C. Self-reported spousal support modifies the negative impact of pain on disability in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2011;78(5):1136–41.
Falahatkar S., Shahab E., Gholamjani Moghaddam K., Kazemnezhad E. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: Results of a prospective pilot double-blind and randomized placebo-controlled study. BJU Int 2015;116(4):641–9.
Wagenlehner F.M., Schneider H., Ludwig M. et al. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 2009;56(3):544–51.
Elist J. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 2006;67(1):60–3.
Morgia G., Mucciardi G., Gali A. et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study. Urol Int 2010;84(4):400–6.
Cai T., Mazzoli S., Bechi A. et al. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. Int J Antimicrob Agents 2009;33(6):549–53.
Perletti G., Marras E., Wagenlehner F.M., Magri V. Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev 2013;8: CD009071.
Lanjouw E., Ouburg S., de Vries H.J. et al. European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS 2015.
Workowski K.A., Bolan G.A., Centers for disease control and prevention. Sexually transmitted disease treatment guidelines, 2015. MMWR Recomm Rep 2015;64(3): 1–137.
Kong F.Y., Tabrizi S.N., Fairley C.K. et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother 2015;70(5):1290–7.
Kong F.Y., Tabrizi S.N., Law M. et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. Clin Infect Dis 2014;59(2):193–205.
Рафальский В.В., Королев С.А. Сравнение эффективности доксициклина и азитромицина при хламидийном уретрите у мужчин: метаанализ рандомизированных исследований. Consilium medicum 2008;10(4). Доступно по:http://con-med.ru/magazines/consilium_medicum/consilium_medicum-04-2008/sravnenie_effektivnosti_doksitsiklina_i_azitromitsina_pri_khlamidiynom_uretrite_u_muzhchin_metaanali/. (Дата обращения 28.05.2016)..
Huang C., Long X., Jing S. et al. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol 2015;34(7):1039–44.
Kouegnigan Rerambiah L., Ndong J.C., Medzegue S. et al. Genital Mycoplasma infections and their resistance phenotypes in an African setting. Eur J Clin Microbiol Infect Dis 2015;34(6):1087–90.
Zhang Z.C., Jin F.S., Liu D.M. et al. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian J Androl 2012;14(6):870–4.
Научный отчет о результатах многоцентрового исследования динамики антибиотикорезистентности возбудителей инфекций мочевых путей в различных субпопуляциях пациентов («ДАРМИС»). Смоленск, 2011. 118 с..
Pontari M.A., Krieger J.N., Litwin M.S. et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 2010;170(17):1586–93.
Камалов А.А., Низов А.Н., Ходырева Л.А., Дударева А.А. Эффективность методов электро- и магнитной стимуляции у больных c синдромом хронической тазовой боли, гиперактивным мочевым пузырем в урологической практике(обзор литературы). Урология 2014;(4):96–9..
Руденко В.И., Рапопорт Л.М., Газимиев М.А. и др. Первый опыт применения ударно-волновой терапии у мужчин с синдромом хронической тазовой боли. Урология 2015; (6):26–9..
Gottsch H.P., Yang C.C., Berger R.E. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. Scand J Urol Nephrol 2011;45(1):72–6.
Тюзиков И.А., Греков Е.А., Калинченко С.Ю., Мартов А.Г. Оптимизация диагностики воспалительных заболеваний предстательной железы на основе междисциплинарного подхода. Экспериментальная и клиническая урология 2013;(1):44–51..
Samplaski M.K., Li J., Shoskes D.A. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 2012;188(5):1788–93.